MB, Levis & Associates’s BlackRock Health Sciences Trust BME Stock Holding History

MB, Levis & Associates’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,500	Closed	-$58K	–	268
2025 Q1	$58K	Sell	1,500 -800	-35%	-$31.7K	0.03%	112
2024 Q4	$87.2K	Hold	2,300	–	–	0.04%	94
2024 Q3	$96.4K	Sell	2,300 -200	-8%	-$8.3K	0.05%	85
2024 Q2	$102K	Sell	2,500 -177	-7%	-$7.04K	0.05%	81
2024 Q1	$111K	Buy	2,677 +40	+2%	+$1.68K	0.06%	79
2023 Q4	$107K	Sell	2,637 -4,894	-65%	-$187K	0.06%	77
2023 Q3	$295K	Buy	7,531 +119	+2%	+$4.74K	0.19%	51
2023 Q2	$301K	Buy	7,412 +112	+2%	+$4.61K	0.19%	51
2023 Q1	$306K	Hold	7,300	–	–	0.21%	49
2022 Q4	$318K	Buy	+7,300	New	+$310K	0.25%	43

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

MB, Levis & Associates's BME Position: Q2 2025 in Review

MB, Levis & Associates sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 1,500 shares — an estimated $58K sold.

MB, Levis & Associates first reported a position in BME in Q4 2022 and held it in 10 quarters. The position peaked at $318K in Q4 2022. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

MB, Levis & Associates reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
MB, Levis & Associates sold 1,500 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $58K.
MB, Levis & Associates first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 10 quarters.
MB, Levis & Associates's BlackRock Health Sciences Trust position peaked at $318K in Q4 2022.
72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on MB, Levis & Associates's 13F filing for Q2 2025, filed 29 Jul 2025.